Clinical Trials Browser

Phase 2 × Panobinostat × Endocrine × Clear all

NCT00985946 2019-12-09

Study of Panobinostat in Patients With Neuroendocrine Tumors

Phase 2 Terminated

15 enrolled 11 charts

Neuroendocrine Tumors

NCT01056601 2017-12-28

Panobinostat & Bortezomib in Pancreatic Cancer Progressing on Gemcitabine Therapy

Phase 2 Terminated

7 enrolled 8 charts

EndocrineGastrointestinal

Glucagonoma, Insulinoma, Pancreatic Neoplasms, Somatostatinoma